Investor's Business Daily5d agoneutral
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In ObesityAnalysts initiated covered Tuesday of IPO stock Kailera Therapeutics, a potential competitor to Lilly and Novo in obesity treatment.
Notícias
Apenas manchetes de alto sinal — eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
51last 24h
1674last 7d
314🟢 bullish (7d)
171🔴 bearish (7d)
136publishers
Investor's Business Daily10d agoneutral
How This Eli Lilly-Tied IPO Stock Fared In Its First QuarterIPO stock Omada Health easily beat first-quarter sales expectations Thursday, and announced a deal with drug titan Eli Lilly.